Needle-free vaccine delivery platform aims to end frozen storage needs and improve access CEPI to initially provide up to US$1.6 million to aVaxziPen to advance development of needle-free vaccine technology aVaxziPen’s innovative vaccine delivery platform aims to improve access to...

aVaxziPen Announces Positive Data in Multiple Diseases on Novel Needle-Free Vaccine, Thermally Stable Delivery Platform at World Vaccine Congress OXFORD, United Kingdom, April 03, 2023 (GLOBE NEWSWIRE) -- aVaxziPen, a biotech company developing a novel needle-free vaccine delivery platform, announces the presentation of data at the World...

University Hospitals Joins Needle-Free Blood Draw Movement, Adopts PIVO™ CLEVELAND, July 18, 2018 (GLOBE NEWSWIRE) -- As part of its ongoing commitment to provide high-quality, patient-centered medical care, University Hospitals (UH) today announced that it has...

Initiation of Phase 3 Clinical Trial on the Patient-controlled Pain Management Drug "SyB P-1501" TOKYO, June 13, 2016 (GLOBE NEWSWIRE) -- SymBio Pharmaceuticals Limited (Headquarters: Tokyo, “SymBio”) announced today that the Phase 3 clinical trial on “SyB P-1501” – a drug for...